XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.20.2

Stock Incentive Plan and Other Equity Activity | 9 Months Ended
--- | ---
Sep. 30, 2020
Stockholders' Equity Note [Abstract] |
Stock Incentive Plan And Other Equity Activity |
14. | STOCK INCENTIVE PLAN AND OTHER EQUITY ACTIVITY
General—The Company has a stock incentive plan (the “Stock Incentive Plan”) and an employee stock purchase plan (the “ESPP”) that are administered by the Compensation and Talent Development Committee of the Board of Directors. Under the Stock Incentive Plan, the Company can issue shares to employees and directors in the form of restricted stock awards (“RSAs”), restricted stock units (“RSUs”) and performance share units (“PSUs”). Changes in common stock, additional paid in capital and treasury stock during the nine months ended September 30, 2020 primarily relate to activity associated with the Stock Incentive Plan, the ESPP and share repurchases. Share Grants—During the nine months ended September 30, 2020, the Company had the following share grants associated with the Stock Incentive Plan:
|  | Shares |  | Weighted Average Grant-Date Fair Value per Share
RSAs |  | 51 |  |  | $ | 8.73 |
RSUs |  | 160 |  |  | $ | 13.72 |
PSUs (at target) |  | 176 |  |  | $ | 14.06 |
Total shares granted |  | 387 |  |  |
Share Issuances—During the nine months ended September 30, 2020, the Company had the following share issuances associated with the Stock Incentive Plan and the ESPP:
|  | Shares
RSAs (issued upon grant) |  | 51 |
RSUs (issued upon vesting) |  | 88 |
PSUs (issued upon vesting) |  | 104 |
ESPP (issued upon sale) |  | 33 |
Total shares issued |  | 276 |
Stock-Based Compensation Expense—During the three and nine months ended September 30, 2020, the Company recognized $1,765 and $7,961, respectively, of stock-based compensation expense, and during the three and nine months ended September 30, 2019, the Company recognized $819 and $2,489 of stock-based compensation expense, respectively, primarily within general and administrative expenses. The Company recognizes forfeitures as they occur, rather than estimating expected forfeitures. Included within total stock-based compensation expense for the three and nine months ended September 30, 2020 is $18 and $54, respectively, of expense related to the ESPP, and during the three and nine months ended September 30, 2019, the Company recognized $12 of expense related to the ESPP. At September 30, 2020, 754 authorized shares remained available for issuance under the ESPP. Shares Withheld for Taxes—The Company withheld 11 and 60 shares for taxes on RSU/PSU stock-based compensation vestings for $105 and $805 during the three and nine months ended September 30, 2020, respectively. The Company withheld 3 and 13 shares for taxes on RSA stock-based compensation vestings for $28 and $150 during the three and nine months ended September 30, 2020, respectively. Warrants—During the nine months ended September 30, 2020, certain holders of warrants elected the cashless exercise option and the Company issued 110 common shares on the exercise of 470 warrants with a market value of $1,477. AOCI—During the three and nine months ended September 30, 2020, changes in AOCI were a result of net gains (losses) recognized in OCI and amounts reclassified from AOCI into earnings related to our interest rate derivative. See Note 11 - Financial Instruments for further discussion of our cash flow hedge.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration